Cargando…
Development of Budesonide Loaded Biopolymer Based Dry Powder Inhaler: Optimization, In Vitro Deposition, and Cytotoxicity Study
The progress in the development of DPI technology has boosted the use of sensitive drug molecules for lung diseases. However, delivery of these molecules from conventional DPI to the active site still poses a challenge with respect to deposition efficiency in the lung. At same time, serious systemic...
Autores principales: | Mali, Ashwin J., Pawar, Atmaram P., Purohit, Ravindra N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590799/ https://www.ncbi.nlm.nih.gov/pubmed/26556201 http://dx.doi.org/10.1155/2014/795371 |
Ejemplares similares
-
Dry Powder and Budesonide Inhalation Suspension Deposition Rates in Asthmatic Airway-Obstruction Regions
por: Murayama, Norihide, et al.
Publicado: (2019) -
Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006) -
Controlled
Pulmonary Delivery of Carrier-Free Budesonide
Dry Powder by Atomic Layer Deposition
por: La Zara, Damiano, et al.
Publicado: (2021) -
Formulation and Evaluation of Optimized Oxybenzone Microsponge Gel for Topical Delivery
por: Pawar, Atmaram P., et al.
Publicado: (2015) -
An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation
por: Marante, Tânia, et al.
Publicado: (2020)